Connection

Yuki Kageyama to Androgen Antagonists

This is a "connection" page, showing publications Yuki Kageyama has written about Androgen Antagonists.
Connection Strength

0.776
  1. Suppression of mutant androgen receptors by flutamide. Int J Urol. 2009 May; 16(5):516-21.
    View in: PubMed
    Score: 0.304
  2. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. Prostate. 2007 Jun 01; 67(8):799-807.
    View in: PubMed
    Score: 0.267
  3. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate. 2008 Oct 01; 68(14):1570-81.
    View in: PubMed
    Score: 0.073
  4. The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):203-11.
    View in: PubMed
    Score: 0.069
  5. Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy. BJU Int. 2006 Jun; 97(6):1184-9.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.